Latest News & Features
Americas
In the life sciences sector, defending broad patent claims can be a tricky business, says Gordon Wright. 16 October 2013
Asia
LSIPR spoke to Jörg Thomaier, chief IP counsel at Bayer, about the state of protection in emerging jurisdictions and the challenges the global company faces in asserting its IP across the world. 16 October 2013
Biotechnology
When it comes to plants, European courts have been occupied with various debates over salad. Margreet van Heuvel and Bart Swinkels take a look. 16 October 2013
Biotechnology
The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe. 16 October 2013
Europe
A German Federal Court decision has given patent applicants in the life sciences field plenty to think about,
as Wolfgang Bublak and Axel Berger explain. 16 October 2013
Asia
Many of the world’s biggest selling drugs have lost exclusivity in recent years, presenting huge opportunities for generic drugs companies but, as LSIPR finds out, it doesn’t have to be a dead end for the innovators. 16 October 2013
Asia
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court. 15 October 2013
Americas
After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York. 15 October 2013
Americas
US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics. 14 October 2013
Americas
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology. 10 October 2013